Trevi Therapeutics, Inc. (TRVI) stock
Close on Nov 13, 2026Market cap $1.94BP/E –Yield –
Trevi Therapeutics statistics
65 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Mar 16, 2027 (estimated, during market hours)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 6.42
- 2.22
Share statisticsIndustry
- Shares Change (YoY)
- 21.7%
- 10.8%
- Shares Change (QoQ)
- 0.08%
- 0.50%
- Float
- 125M
- 49M
- Shares Held by Insiders
- 12.4%
- 11.7%
- Shares Held by Institutions
- 105.7%
- 56.4%
Short sellingIndustry
- Short Interest
- 17M
- –
- Short Interest Change
- 5.30%
- -0.80%
- Short % of Float
- 13.5%
- 9.01%
- Short % of Shares Outstanding
- 11.8%
- 6.30%
- Days to Cover
- 10.13
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $20.22
- –
- 52-Week Low
- $9.82
- –
- 20-Day Moving Average
- $13.54
- –
- 50-Day Moving Average
- $14.03
- –
- 200-Day Moving Average
- $14.52
- –
- Average True Range (14)
- $0.91
- –
- Price Change (1 Week)
- -4.75%
- -1.15%
- Price Change (1 Month)
- 12.7%
- -4.87%
- Price Change (3 Months)
- -26.1%
- -21.0%
- Price Change (6 Months)
- -3.87%
- -20.6%
- Price Change (YTD)
- 9.03%
- -23.6%
- Price Change (1 Year)
- 15.2%
- -22.4%
- Price Change (3 Years)
- 854.5%
- -29.5%
- Price Change (5 Years)
- 1097.4%
- -77.9%
- Average Volume (10 Days)
- 2M
- –
- Average Volume (20 Days)
- 2M
- –
- Average Volume (90 Days)
- 2M
- –
- Relative Volume
- 0.55
- 0.70
- Relative Strength Index (14)
- 48.5
- 43.4
- Volatility (1 Year)
- 59.2%
- 80.1%
- Beta (5 Years)
- 0.87
- 1.07
Returns on capitalIndustry
- Return on Equity (ROE)
- -24.7%
- -49.9%
- Return on Assets (ROA)
- -23.8%
- -40.6%
- Return on Capital Employed (ROCE)
- -23.1%
- -37.9%
Financial positionIndustry
- Current Ratio
- 38.86
- 3.30
- Quick Ratio
- 38.05
- 2.39
EfficiencyIndustry
- Profits Per Employee
- -$1.79M
- -$689.41K
- Employee Count
- 34
- 74
- WACC
- 9.47%
- 10.2%
Income statement (TTM)Industry
- Pretax Income
- -$60.83M
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- $299.41M
- $17.76M
- Net Cash Per Share
- $2.10
- $0.80
- Equity (Book Value)
- $302.76M
- $53.89M
- Book Value Per Share
- $2.12
- $1.50
- Tangible Book Value
- $302.76M
- $27.13M
- Working Capital
- $297.93M
- $79.99M
Cash flow (TTM)Industry
- Capital Expenditures
- -$251.00K
- -$1.00M
- FCF Per Share
- -$0.43
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -3.12%
- -21.8%
- FCF Yield
- -3.17%
- -9.44%
Taxes and interestIndustry
- Income Tax
- -$74.00K
- $73.00K
Scores and fair valueIndustry
- Altman Z-Score
- 143.53
- 0.23
- Piotroski F-Score
- 4
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | TRVI | S&P 500 | Difference | TRVI per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +11.1% | -3.0% | +14.1 pts | ||
| 3 months | -24.8% | -2.8% | −22.0 pts | ||
| Year to date | +9.0% | +11.5% | −2.5 pts | ||
| 1 year | +19.1% | +13.5% | +5.6 pts | ||
| 3 years | +918.7% | +77.7% | +841.0 pts | +116.8% | +21.1% |
| 5 years | +1097.4% | +72.6% | +1024.8 pts | +64.3% | +11.5% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
17M TRVI shares were sold short on Oct 30, 2026, up 5.3% from the previous report, or 13.51% of the shares available to trade. At recent volumes it would take 10.1 days to buy them back. Over the last 20 sessions, 58.1% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 16,855,987 | +5.3% | 1,663,689 | 10.1 |
| Oct 15, 2026 | 16,007,187 | +9.3% | 3,582,888 | 4.5 |
| Sep 30, 2026 | 14,639,150 | +21.3% | 1,756,639 | 8.3 |
| Sep 15, 2026 | 12,070,625 | +0.5% | 1,373,723 | 8.8 |
| Aug 31, 2026 | 12,012,371 | -5.1% | 1,494,034 | 8.0 |
| Aug 14, 2026 | 12,657,630 | -3.7% | 1,617,552 | 7.8 |
| Jul 31, 2026 | 13,147,012 | +3.9% | 2,434,305 | 5.4 |
| Jul 15, 2026 | 12,653,483 | -8.8% | 2,659,448 | 4.8 |
| Jun 30, 2026 | 13,870,118 | -3.4% | 3,465,819 | 4.0 |
| Jun 15, 2026 | 14,351,654 | +5.7% | 971,606 | 14.8 |
| May 29, 2026 | 13,574,699 | +2.1% | 1,094,911 | 12.4 |
| May 15, 2026 | 13,289,352 | -13.1% | 1,525,091 | 8.7 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?